First COVID-19 vaccine candidate COVAXIN from India gets DCGI approval for human trials
India's first antibody up-and-comer against the novel coronavirus, COVAXIN, has gotten a gesture from the Drug Controller General of India (DCGI) for additional clinical preliminaries Phase I and 2 in tainted individuals. The antibody is a work in progress by Hyderbad-based biotechnology firm Bharat Biotech as a team with [...]
